Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 17, 2012 - Issue 1
Submit an article Journal homepage
388
Views
33
CrossRef citations to date
0
Altmetric
Mini Reviews

Cannabinoid-1 receptor (CB1R) blockers as medicines: beyond obesity and cardiometabolic disorders to substance abuse/drug addiction with CB1R neutral antagonists

David R. JaneroNortheastern University, Bouvé College of Health Sciences, Department of Pharmaceutical Sciences and Center for Drug Discovery, 360 Huntington Avenue, 116 Mugar Life Sciences Hall, Boston, MA 02115-5000, USA+1 617 373 2208; +1 617 373 7493; [email protected]
, PhD
Pages 17-29 | Published online: 16 Feb 2012

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.